3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
44
Liver Neoplasms
18
Colorectal Neoplasms
15
Neoplasm Metastasis
11
Cholangiocarcinoma
11
Pancreatic Neoplasms
9
Colonic Neoplasms
9
Barrett Esophagus
7
Rectal Neoplasms
6
Recurrence
5
Esophageal Neoplasms
4
Biliary Tract Neoplasms
3
Bile Duct Neoplasms
3
Hepatitis B
2
Gallbladder Neoplasms
2
Stomach Neoplasms
1
Solid Tumor Including Thyroid, Bone, Liver, Pancreas
1
Pancreatic cancer, adult
1
Pancreatic Neuroendocrine Tumors, WHO Grade I-II
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasms, Glandular and Epithelial
1
Neoplasms
1
Neoplasm Micrometastasis
1
Multi-organ Metastatic Colorectal Cancer
1
Liver Metastasis Colon Cancer
1
Klatskin Tumor
1
Jaundice, Obstructive
1
Hypertension, Portal
1
Hepatitis B, Chronic
1
Interventions
Bevacizumab
2
regorafenib
1
Radiofrequency Ablation
1
PSMA-BCH
1
Oxaliplatin
1
IFL protocol
1
FOLFOXIRI protocol
1
Electroporation
1
Cetuximab
1
CPG-oligonucleotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Metastasis Colon Cancer
×
Radiofrequency Ablation
×
Gastrointestinal
×
Clear all
NCT04798898
2024-12-05
ISCOLIM
University of Aarhus
Phase NA
Recruiting
200 enrolled